These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15662690

  • 1. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons.
    van den Berg M, Timmermans DR, Kleinveld JH, Garcia E, van Vugt JM, van der Wal G.
    Prenat Diagn; 2005 Jan; 25(1):84-90. PubMed ID: 15662690
    [Abstract] [Full Text] [Related]

  • 2. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA, Bleker OP, Bonsel GJ, Bilardo CM.
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [Abstract] [Full Text] [Related]

  • 3. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
    Stefansdottir V, Skirton H, Jonasson K, Hardardottir H, Jonsson JJ.
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):931-8. PubMed ID: 20235896
    [Abstract] [Full Text] [Related]

  • 4. [A qualitative study of pregnant women's choice of nuchal translucency measurement].
    Lou S, Dahl K, Risør MB, Hvidman LE, Thomsen SG, Jørgensen FS, Olesen F, Kjaergaard H, Kesmodel U.
    Ugeskr Laeger; 2007 Mar 05; 169(10):914-8. PubMed ID: 17359736
    [Abstract] [Full Text] [Related]

  • 5. Informed decision making in the context of prenatal screening.
    van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G.
    Patient Educ Couns; 2006 Oct 05; 63(1-2):110-7. PubMed ID: 16242899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458].
    Nagle C, Gunn J, Bell R, Lewis S, Meiser B, Metcalfe S, Ukoumunne OC, Halliday J.
    BJOG; 2008 Feb 05; 115(3):339-47. PubMed ID: 18190370
    [Abstract] [Full Text] [Related]

  • 11. Does offering and performing prenatal screening influence women's attachment to their unborn child? A longitudinal randomized controlled trial.
    Kleinveld JH, Timmermans DR, van den Berg M, van Eijk JT, Ten Kate LP.
    Prenat Diagn; 2007 Aug 05; 27(8):757-64. PubMed ID: 17546705
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. On what grounds do women participate in prenatal screening?
    Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynänen M.
    Prenat Diagn; 1998 Feb 05; 18(2):153-65. PubMed ID: 9516017
    [Abstract] [Full Text] [Related]

  • 15. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome.
    Khoshnood B, De Vigan C, Blondel B, Lhomme A, Vodovar V, Garel M, Goffinet F.
    Ultrasound Obstet Gynecol; 2006 Sep 05; 28(3):242-8. PubMed ID: 16909402
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R, Duchange N, Vayssière C, Kohler M, Bouffard N, Hunsinger MC, Kohler A, Mager C, Neumann M, Vayssière C, Viville B, Hervé C, Moutel G.
    Prenat Diagn; 2007 Mar 05; 27(3):197-205. PubMed ID: 17238219
    [Abstract] [Full Text] [Related]

  • 20. Mexican women's reasons for accepting or declining HIV antibody testing in pregnancy.
    Romero-Gutiérrez G, Delgado-Macías AA, Mora-Escobar Y, Ponce-Ponce de León AL, Amador N.
    Midwifery; 2007 Mar 05; 23(1):23-7. PubMed ID: 16928410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.